Donor stem cell transplant shows promise for myeloma patients under 65

This study tested whether a stem cell transplant from a matched donor could improve outcomes for myeloma patients under 65 who had already responded well to their own stem cell transplant. Thirteen patients received a reduced-intensity conditioning regimen followed by the donor transplant. The main goal was to see if this approach could increase the number of patients alive without the disease getting worse three years later. The study also looked at side effects, including graft-versus-host disease, and the use of bortezomib after transplant.